Clinical Trial Update: ATS907 Ph2a Open-Label Dose-ranging Safety and Tolerability in Primary Open Angle Glaucoma (POAG) and Ocular Hypertension (OHT) Subjects [Phase 2]

View source ↗

Summary

Phase 2a open-label dose-ranging study assessing safety and tolerability of ATS907 in primary open-angle glaucoma and ocular hypertension. The trial has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• ATS907 (ATS907)

Snippet

Sponsor: Altheos, Inc. | Conditions: Primary Open Angle Glaucoma, Ocular Hypertension | Phase 2 | Status: COMPLETED